General Information
Revision date
2007-07-19
Product name
Common/Trade Name: Pamidronate Disodium for Injection (30 mg per vial)
Product Synonyms
ArediaTM , Pamidronate Disodium, CGP 23339A, Disodium Pamidronate, Disodium 3- amino-1-hydroxypropylidene-1,1-biphosphate
Chemical name
Phosphoric acid,(3-amino-1-hydroxypropylidene)bis-,disodium salt
Manufacturer Name
BEN VENUE LABORATORIES, INC
Emergency telephone
Professional Services 1(800) 521-5169
Icons in SDS
Company Information
company name
BEN VENUE LABORATORIES, INC
Section 2
Principle Routes of Exposure
Exposure may occur via inhalation, ingestion, injection or skin contact
Health hazards
Acute & Chronic) Product is a bone-resorption inhibitor and may affect the digestive and blood systems. Chronic exposure may affect the kidneys and bone. Carcinogenicity: NTP? NO IARC Monographs? NONE OSHA Regulated? NO Signs & Symptoms of Exposure: May cause irritation to eyes and skin. Excessive exposure may cause pain, fatigue, transient fever, gastrointestinal disturbances and fluctuations in serum calcium and mineral levels.
Medical Conditions Generally Aggravated by Exposure
Persons who are allergic to Pamidronate Disodium or other bisphosphates. BVL Hazard Category: 2 1